A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

Austria

Universitätsklinik für Innere Medizin, Graz

Denmark

Odense University Hospital (UNIODE), Odense

Italy

Azienda Ospedaliero Universitaria di Bologna, Bologna

Norway

St. Olavs Hospital, Trondheim

Spain

Hospital Sant Joan de Deu, Esplugues de Llobregat